The Week in Review in Drug Pricing

1. Let. Medicare. Negotiate.

  • A leaked draft of a House plan to empower the U.S. government to negotiate drug prices injects enthusiasm into the drug pricing debate and overlaps with President Trump’s plan. — (NYT/FiercePharma)

2. Momentum grows for Senate Finance Bill

  • Republican lawmakers are voicing their support to the Senate’s bipartisan effort to lower drug prices by curtailing price hikes and lowering out-of-pocket costs in Medicare. — (Press Herald)


3. Speak out

  • P4AD Digital Director Samantha Reid describes what it’s like to live with the financial uncertainty illness brings. High drug prices for drugs to treat Crohn’s disease certainly don’t help! — (Twitter)


4. On the take

  • The first six months of 2019 saw $4 million in pharma campaign finance donations pour into lawmakers' coffers. See who’s got their hand in the pill cash jar. — (KFF)


5. No, really. LOWER DRUG PRICES

  • The latest polling again shows the public wants Congress to make lowering drug prices a top priority. — (KFF)